Tehran, July 1, MPO_ IRCS President announced the trial production of new dialysis filter (Plus series) in Helal Iran Medical Devices Company, and hopes this new and strategic dialysis filter being produced according to ISO8637 and which has high potential in protecting the bloodstream against the entrance of endotoxins into it, enters production stage by March 21st.
As reported by MPO Public Relations citing
from IRCS' Website, Prof. Ali Asghar Peyvandi, IRCS President told IRNA that some of
the features of this new dialysis filter include improving the quality indexes
of filter such as its excellent blood compatibility with blood, fibre
micro-undulation for the effective flow of dialysis solution, and suitable
purification of small toxins of the uremic molecule in bloodstream; the item is
produced according to the ISO8637standard requirements and has high potential
for protection against endotoxins into the bloodstream.